ChartRow logo
Data provided bySource: Twelve Data
GMED
$69.99-0.72%
as of close, Nov 17, 2026
☾ AH $69.99 -0.72%
PeersSNNPODDZBHSTEBIOPEN
Share this page

GMED — Globus Medical Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in GMED be worth today? →
GMED returns: By year · By month · By week · Trailing

Price data

Price
$69.99
YTD price return
-19.84%
YTD total return
-19.84%
Market cap
9.3B
Enterprise value
8.9B
Shares outstanding
132.5M
52W low
$69.49
52W high
$101.40
From 52W high
-30.98%
From 52W low
+0.72%
52W range
2%$69.49–$101
Beta
0.96

Volume

Rel volume
0.62×
30D volume
1.8M
30D $ vol
140.5M

Insider trading

Insider net 1W
none
Insider net 1M
−$3.6M
Insider net 3M
−$5.8M
Insider net 1Y
−$13.3M

Form 4 transactions by trade date, as filed; latest on file 2026-11-10.

Fundamentals

Sales (ttm)
3.1B
Sales/share
$23.70
EPS (ttm)
$4.07
FCF (ttm)
766.5M
FCF/share
$5.79
Book value/share
$36.21
Net margin
17.76%
ROE
11.63%
ROA
10.09%
Current ratio
4.30

Growth (CAGR, ttm) · 10Y

Sales
+13.36%+36.79%+22.09%+18.92%
Net income
+31.61%+52.27%+24.42%+16.84%
FCF
+32.28%+81.07%+23.93%+19.92%
Shares
-1.02%+4.75%+5.48%+3.29%

Per-share growth (CAGR, ttm) · 10Y

EPS
+32.39%+39.49%+17.59%+12.80%
Sales/share
+14.53%+30.58%+15.75%+15.13%
FCF/share
+33.65%+72.86%+17.50%+16.09%
Book value/share
+10.17%-0.12%+16.42%+15.66%
Price
-16.33%+15.37%-0.15%+12.82%
Total return
-16.33%+15.37%-0.15%+12.82%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
17.2×
P/OI (ttm)
13.6×
Fwd P/E
13.1×
P/S (ttm)
3.0×
P/B (mrq)
1.9×
P/FCF (ttm)
12.1×
EV/EBITDA (fy)
9.2×
EV/Sales (ttm)
2.8×
FCF yield (ttm)
8.27%
Buyback yield (realized, 1y)
0.59%
Shareholder yield (realized, 1y)
0.59%
Buyback yield (cash, ttm)
3.49%
Shareholder yield (cash, ttm)
3.49%

Vs own 10Y history

P/E
0th
P/OI
1st
P/S
2nd
P/B
10th
P/FCF
0th

Bar = where today’s multiple sits in GMED’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-17#

Data provided bySource: Twelve Data
1D
-0.72%
5D
-6.97%
1M
-8.76%
3M
-17.77%
YTD
-19.84%
1Y
-16.32%
5Y
-0.72%
1D
-0.72%
5D
-6.97%
1M
-8.76%
3M
-17.77%
YTD
-19.84%
1Y
-16.32%
5Y
-0.72%

Fundamentals#

Revenue

5Y CAGR +30.1%10Y CAGR +18.4%YoY −0.7%
$3.1B TTM$763.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR +33.9%10Y CAGR +10.8%YoY +29.3%
$679.7M TTM$177.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y CAGR +31.2%10Y CAGR +12.9%YoY +18.2%
$4.07 TTM$1.04 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +34.2%10Y CAGR +23.2%YoY +5.1%
$766.5M TTM$224.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM

TTM: operating cash flow $925.9M, capex −$159.4M

Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Q3 2026: operating cash flow $265.2M, capex −$40.4M

Shares (diluted)

5Y +35.7%10Y +42.7%YoY +0.5%
137M TTM136M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y CAGR +39.4%10Y CAGR +16.9%YoY +18.7%
$557.6M TTM$141.2M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q3 '16Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q3 '20Q2 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Full GMED financials →

Globus Medical Inc. Class A Common Stock represents ownership in Globus Medical, a medical device company focused on musculoskeletal care. The company develops and commercializes products for spine and orthopaedic applications, including implant systems, surgical instruments, and enabling technologies used in hospitals, physician practices, and surgical centers. Its portfolio supports procedures for spinal disorders, bone healing, and other complex musculoskeletal conditions, making it a significant supplier in the healthcare equipment market. Globus Medical also provides integrated solutions that combine devices, instrumentation, and technology to support surgical workflows and patient treatment. Headquartered in Audubon, Pennsylvania, Globus Medical serves healthcare providers in the United States and internationally.

Audubon, PA·6,000 employees·Medical Devices·globusmedical.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding GMED#

18 of the 193 ETFs ChartRow carries live hold GMED. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VBKVanguard Small-Cap Growth ETF0.3%
IJHiShares Core S&P Mid-Cap ETF0.2%
MDYSPDR S&P MidCap 400 ETF Trust0.2%
VHTVanguard Health Care ETF0.1%
VBVanguard Small-Cap ETF0.1%
VXFVanguard Extended Market ETF0.1%
IWSiShares Russell Mid-Cap Value ETF0.1%
IWRiShares Russell Midcap ETF0.1%
TickerName1M1D
LLYEli Lilly and Company+12.61%-1.13%
JNJJohnson & Johnson+9.05%-1.36%
ABBVAbbVie Inc.+2.59%-0.59%
MRKMerck & Co. Inc.-1.77%-0.75%
UNHUnitedHealth Group Incorporated Common Stock (DE)-2.93%-5.42%
NVSNovartis AG+5.65%-0.67%
TMOThermo Fisher Scientific Inc.-0.47%-0.66%
AMGNAmgen Inc.+5.88%-0.95%